Albert Bourla, Pfizer CEO (Lintao Zhang/Getty Images)
October 10, 2024 11:15 AM EDTUpdated 01:49 PM
People
Pharma

Ex­clu­sive: How an ac­ci­den­tal email tipped Pfiz­er off to an ac­tivist in­vestor’s plan

Drew Armstrong

Executive Editor

Max Bayer

Pharma Reporter

The mes­sage over the week­end to Pfiz­er’s CEO Al­bert Bourla was blank. But it con­tained a warn­ing nonethe­less.

It came from his for­mer CFO Frank …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Star­board launch­es first sal­vo in Pfiz­er fight, al­leg­ing ex-CEO, CFO were pres­sured to flip

For­mer Pfiz­er CEO and CFO flip on ac­tivist and say they now sup­port com­pa­ny

Grit­stone files for bank­rupt­cy, says it could forge a trans­ac­tion as ear­ly as this month to keep R&D go­ing

Ono’s ADC deal; Leo Phar­ma to con­duct lay­offs

AI biotechs Re­cur­sion and Ex­sci­en­tia first held deal talks in 2022

Sen. War­ren urges FTC to ‘care­ful­ly scru­ti­nize’ No­vo-Catal­ent deal over com­pe­ti­tion con­cerns

A service from the Financial Times